<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The development of distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is associated with poor outcome in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The stromal cell-derived factor-1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4) have pivotal roles in the chemotaxis of migrating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells during <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, hampering the SDF-1/CXCR4 cross-talk is a promising strategy to suppress <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We investigated the invasive behavior of the lentivirally CXCR4 overexpressing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines SW480, SW620 and RKO in chemotaxis and invasion assays toward an SDF-1α gradient </plain></SENT>
<SENT sid="4" pm="."><plain>Low endogenous CXCR4 expression levels were determined by quantitative realtime polymerase chain reaction (PCR) and fluorescence-activated cell sorting (FACS) analyses </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A lentiviral CXCR4 overexpression and knockdown model was established in these <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>In transwell migration assays, CXCR4 overexpression favored chemotaxis and invasion of cells in <z:hpo ids='HP_0000001'>all</z:hpo> 3 lines depending on an SDF-1α gradient (p &lt; 0.001 vs. untransduced cells) </plain></SENT>
<SENT sid="7" pm="."><plain>Functional CXCR4 knockdown using lentiviral short hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> (shRNA) vectors significantly decreased the migration behavior in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines (p &lt; 0.001), confirming a CXCR4-specific effect </plain></SENT>
<SENT sid="8" pm="."><plain>Pharmacologic inhibition of the SDF-1α/CXCR4 interaction by the bicyclam Plerixafor(TM) at 100 μM significantly abrogated CXCR4-dependent migration and invasion through Matrigel(TM) (SW480, SW620, RKO; p &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our results indicate that a CXCR4-antagonistic therapy might prevent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell dissemination and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, consequently improving survival </plain></SENT>
</text></document>